Invention Grant
- Patent Title: Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer
-
Application No.: US15503809Application Date: 2015-08-14
-
Publication No.: US10363249B2Publication Date: 2019-07-30
- Inventor: Timothy Sean Heuer
- Applicant: 3-V Biosciences, Inc.
- Applicant Address: US CA San Mateo
- Assignee: 3-V Biosciences, Inc.
- Current Assignee: 3-V Biosciences, Inc.
- Current Assignee Address: US CA San Mateo
- Agency: Cooley LLP
- International Application: PCT/US2015/045244 WO 20150814
- International Announcement: WO2016/025816 WO 20160218
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K45/06 ; A61K31/00 ; A61K31/337 ; A61K31/4178 ; A61K47/64 ; A61K47/69
Abstract:
Compounds that are fatty acid synthesis modulators are provided. The compounds may be used in pharmaceutical compositions to treat taxane-resistant cancers. Methods are provided for treating taxane-resistant cancer in a subject. Methods are also provided for increasing the sensitivity of a cancer cell to taxanes (i.e., paclitaxel, Nab-paclitaxel docetaxel, and/or cabazitaxel) treatment.
Public/Granted literature
- US20170273964A1 FATTY ACID SYNTHASE INHIBITOR FOR USE IN THE TREATMENT OF DRUG RESISTANT CANCER Public/Granted day:2017-09-28
Information query
IPC分类:
